Ichida F., Fatica NS, O'Loughlin JE, et al. Epidemiologic aspects of Kawasaki disease in a Manhattan hospital . Pediatrics.1989;84:235-241.
3.
Kawasaki T., Kosaki F., Okawa S., et al. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics. 1974 ;54:271-276.
4.
Kegel SM, Dorsey TJ, Rowen M., et al. Cardiac death in mucocutaneous lymph node syndrome. Am J Cardiol.1977;40:282-286.
5.
Magilavy DB, Speert DP, Silver TM, et al. Mucocutaneous lymph node syndrome: report of two cases complicated by gall-bladder hydrops and diagnosed by ultrasound. Pediatrics . 1978;61:699-702.
6.
Reller M., DeCristofaro J., Schwartz DCCoronary aneurysms in a patient with atypical Kawasaki syndrome and a streptococcal infection. Pediatr Cardiol.1984;5:205-208.
7.
Melamed I., Diamant S., Fattal A., et al. Kawasaki disease with serological evidence of streptococcal infection. Infection.1986;14:91-92.
8.
Krensky AM, Teele R., Watkins J., et al. Streptococcal antigenicity in mucocutaneous lymph node syndrome and hydropic gallbladders. Pediatrics, 1979 ; 64:979-980.
9.
Dean AG, Melish ME, Hicks R., et al. An epidemic of Kawasaki syndrome in Hawaii. J Pediatr.1982;100:552-557.
10.
Hokonohara M., Yoshinaga M., Baba Y.Study of antibody response to 4 streptococcal antigens in rheumatic fever and Kawasaki disease with or without cardiovascular lesions. Jpn Circ J. 1987;51:1353-1356.
11.
Kotani S.Evaluation of evidence related to streptococci in the etiology of Kawasaki disease. Prog Clin Biol Res.1987;250:101-111.
12.
Management of Kawasaki syndrome: a consensus statement by North American participants of the Third International Disease Symposium , Tokyo, Japan, December, 1988. Pediatr Infect Dis J. 1989;8:663-665.
